Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Gains from Investment Securities (2016 - 2025)

Nephros has reported Gains from Investment Securities over the past 14 years, most recently at $1000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $1000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $6000.0 (down 99.12% YoY), and the annual figure for FY2025 was $1.3 million, up 8.62%.
  • Gains from Investment Securities for Q4 2025 was $1000.0 at Nephros, down from $14729.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for NEPH hit a ceiling of $674000.0 in Q4 2022 and a floor of $500.0 in Q2 2025.
  • Median Gains from Investment Securities over the past 5 years was $85198.0 (2024), compared with a mean of $130461.6.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 99.55% in 2023 and later skyrocketed 10128.75% in 2025.
  • Nephros' Gains from Investment Securities stood at $223000.0 in 2021, then skyrocketed by 202.24% to $674000.0 in 2022, then plummeted by 99.55% to $3000.0 in 2023, then skyrocketed by 2739.93% to $85198.0 in 2024, then crashed by 98.83% to $1000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $1000.0 (Q4 2025), $14729.0 (Q3 2025), and $500.0 (Q2 2025) per Business Quant data.